High Spending and Doctorate Production institution, as designated by the Carnegie Classification of Institutions of Higher ...

Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA’s Additional Information Request (AIR) ...

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed” or the "Company”) today ...

A new study found a link between citrus consumption and a bacteria that lowers the risk of developing depression by 20%. What ...

Clinical care changes that ended racial disparities in early-stage breast and lung cancer also boosted outcomes for all ...

Rhumbline Advisers raised its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 2.1% in the fourth ...

His research focuses on viral zoonoses presenting risk factors for human contamination. As principal investigator and co-investigator for several university and US-funded grants, Dr. Mbala laid the ...

Colorectal cancer, the second most common cause of cancer-related death, affects almost 2 million people worldwide every year.

Truist Financial Corp raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 0.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...

The first development is the publication of a new book, Doctored, by American investigative journalist Charles Piller, which ...

Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more concerned about young Americans ...

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...